Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Clinical Nephrology
You have accessRestricted Access

The Heart of Children with Steroid-Resistant Nephrotic Syndrome: Is It All Podocin?

Yaacov Frishberg, Sofia Feinstein, Choni Rinat, Rachel Becker-Cohen, Israela Lerer, Annick Raas-Rothschild, Benjamin Ferber and Amiram Nir
JASN January 2006, 17 (1) 227-231; DOI: https://doi.org/10.1681/ASN.2005060653
Yaacov Frishberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofia Feinstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Choni Rinat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Becker-Cohen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Israela Lerer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annick Raas-Rothschild
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Ferber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amiram Nir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Mutations in the gene NPHS2 encoding podocin are responsible for a recessive form of steroid-resistant nephrotic syndrome (SRNS). The common phenotype is of massive proteinuria in early childhood that tends to progress to end-stage renal failure. Extrarenal manifestations have not been described. Twenty-two children with SRNS from six unrelated Arab families were found to be homozygous for the R138X mutation in NPHS2. Eighteen patients underwent cardiac evaluation at diagnosis of SRNS while they had normal BP and preserved renal function. Cardiac anomalies were detected in 16 (89%) children: Left ventricular hypertrophy in eight, pulmonary stenosis in six, discrete subaortic stenosis in two, and Ebstein anomaly and ventricular septal defect in one each. The remaining four affected individuals were assessed only once they had end-stage renal failure. They had severe left ventricular hypertrophy and experienced repeated episodes of heart failure. Two control groups were equally evaluated. The first consisted of 37 siblings without nephrotic syndrome, of whom only one carrier had a cardiac defect (P < 0.001). None of the second group, which included 22 children with persistent nephrotic syndrome as a result of other causes, had a cardiac anomaly (P < 0.001). Cardiac disorders in homozygotes for mutations in NPHS2 cannot be attributed to an association by chance or to a state of persistent nephrotic syndrome. Because human podocin mRNA is expressed in fetal heart, it is speculated that it may have a role in normal cardiac development. Cardiac evaluation is recommended at the time of diagnosis of SRNS due to mutations in podocin.

Nephrotic syndrome (NS) is defined as the combination of massive proteinuria, hypoalbuminemia, and edema. In recent years, the molecular bases of several conditions that lead to steroid-resistant nephrotic syndrome (SRNS) have been identified (1,2). The common denominator shared by these clinical entities is that they all result from a structural defect in the glomerular barrier, thus explaining their unresponsiveness to immunosuppressive agents (3). There is significant overlap between these disorders with respect to the age of onset, the severity of NS, the histologic findings, and the clinical outcome. The congenital NS of the Finnish type (CNF) is caused by mutations in the NPHS1 gene encoding nephrin, which is expressed in the slit diaphragm joining the podocyte foot processes (4). Mutations in ACTN4, encoding α-actinin-4, cause a dominant form of focal segmental glomerulosclerosis (FSGS) (5). A recessive form of SRNS was found to result from mutations in NPHS2 encoding a protein named podocin as a result of its specific expression in podocytes (6).

We previously reported that a founder mutation in podocin (R138X) is a prevalent cause of SRNS in Arab children (7). Subsequently, it was noted that a number of these patients have a co-existing cardiac disorder. Only a few case reports described an association between SRNS and cardiac defects (8,9). The aim of this study was to review systematically the cardiac status of these SRNS patients at the time of diagnosis and during the course of the disease. This was particularly intriguing because genetic glomerular barrier disorders have been considered to be kidney specific.

Materials and Methods

Twenty-two children (12 male) with SRNS from six consanguineous kindreds of Arab descent have been diagnosed and treated in our center. These families are unrelated to each other. Genetic analysis showed that all of the patients were homozygous for the nonsense R138X mutation in NPHS2, encoding podocin. Four children were referred to our center once they already had ESRD, and the diagnosis of SRNS was based on clinical characteristics and confirmed by genetic studies. These patients lacked comprehensive cardiac assessment at the time of diagnosis of SRNS but underwent complete evaluation once renal replacement therapy was initiated.

Cardiac evaluation that was performed within 0.9 ± 1.5 mo from the time of diagnosis in the remaining 18 children included physical examination, chest radiogram, electrocardiogram, and echocardiography. Echocardiogram was performed by senior pediatric cardiologists using a Sonos 2000 machine. The study included detailed M-mode measurements, two-dimensional echocardiography, and color Doppler interrogation. Left ventricular hypertrophy (LVH) was defined as left ventricular septum or posterior wall thickness that was greater than the 90th percentile for body surface area (10). All patients were subsequently followed on a regular basis by the pediatric cardiology team.

Chronic kidney disease (CKD) was defined as calculated GFR <80 ml/min per 1.73 m2. Two control groups were selected. The first one consisted of 37 siblings (19 male) without NS, and the second group included 22 children (13 male) with persistent NS as a result of various causes other than mutations in podocin. NS in the second control group was due to isolated diffuse mesangial sclerosis in five children, membranoproliferative glomerulonephritis in four, steroid-dependent NS in four, FSGS in three, CNF and Alport syndrome in two each, and familial Mediterranean fever (FMF)-associated amyloidosis and Henoch-Schönlein nephritis in one each. Children of both control groups underwent complete cardiac evaluation. Comparison of proportions of cardiac anomalies between the various groups was performed using t test. This study was approved by the Ethics Committee of the Shaare Zedek Medical Center.

Results

SRNS was diagnosed at the mean age of 2.3 ± 3.1 yr with neonatal presentation in three infants. Sixteen children from this cohort reached ESRD during their first decade of life, and eight underwent kidney transplantation.

Cardiac anomalies were detected in 16 (89%) of 18 children at the time of diagnosis of SRNS, while they all had normal BP and preserved kidney function (Table 1). The most common finding was of LVH, detected in eight children, followed by pulmonary stenosis (valvular, supravalvular, or peripheral pulmonary artery stenosis) in six children. Discrete subaortic stenosis was detected in two children, whereas Ebstein anomaly of the tricuspid valve and ventricular septal defect were detected in one patient each. Only two children had a normal cardiac examination at diagnosis of SRNS.

View this table:
  • View inline
  • View popup
Table 1.

Cardiac anomalies in children with steroid-resistant nephrotic syndrome as a result of mutations in podocina

Factors such as anemia and hypocalcemia, which potentially could have an impact on the cardiac abnormalities, were evaluated at the time of diagnosis of SRNS and were excluded. The mean serum hemoglobin level was 11.1 ± 1.1 g/dl, and the mean serum ionized calcium was 1.23 ± 0.048. The mean plasma albumin was 1.8 ± 0.4 g/dl.

In two instances, the diagnosis of cardiac defect preceded that of NS. Patient G-1 (Table 1) was evaluated for generalized weakness at the age of 11 yr. Echocardiography revealed severe pulmonary valve stenosis with a gradient of 78 mmHg, which was managed successfully by balloon valvuloplasty. One year later, his 2.5-yr-old brother (G-2) was diagnosed with SRNS, and screening of all siblings demonstrated that G-1 had asymptomatic NS with a homozygous R138X genotype. Patient AR-4 was referred to a pediatric cardiologist for evaluation of shortness of breath and edema. Echocardiography showed concentric hypertrophic cardiomyopathy, and a complete work-up led to the diagnosis of SRNS.

Intrafamilial variability in cardiac defects was demonstrated in several kindreds. M-1 and M-2 are second cousins (Figure 1): One had Ebstein anomaly of the tricuspid valve, and the other had peripheral pulmonary artery stenosis with biventricular hypertrophy. In family AR (Figure 1), four children received a diagnosis of LVH, and three received a diagnosis of pulmonary stenosis. In family S, one child had hypertrophic cardiomyopathy, and the other two had discrete subaortic stenosis. In one child (S-2), it mandated two cardiac surgeries in which a membrane was resected. His most recent echocardiography showed no residual stenosis.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Pedigrees of six families with steroid-resistant nephrotic syndrome (SRNS) as a result of the homozygous R138X mutation in NPHS2 encoding podocin, demonstrating co-inheritance with cardiac defects. Full symbol, homozygote; half-full symbol, heterozygote; empty symbol, healthy; Embedded Image, cardiac anomaly detected at diagnosis of SRNS; Embedded Image, cardiac anomaly detected when patient had ESRD.

Analysis of serial echocardiograms among our study patients demonstrated mild to severe LVH already at the time of diagnosis of SRNS, before the development of CKD, which was documented much later at the mean age of 5.1 ± 2.5 yr. Further augmentation in LVH was noted with age, concomitant with the development of significant hypertension and gradual decline in renal function. LVH peaked with onset of ESRD, leading to reduction in left ventricular systolic function and resulting in repeated episodes of congestive heart failure. Six of eight patients with LVH were treated with angiotensin-converting enzyme inhibitors as antiproteinuric agents. This therapeutic modality had absolutely no effect on the course of LVH.

Four children who received a diagnosis of LVH, early in life and before hypertension or renal failure evolved, underwent a successful kidney transplantation at the mean age of 6.5 ± 1.1 yr. It is interesting that complete resolution of their LVH occurred within a period of 2 to 4 yr at the mean age of 9.2 ± 1.2 yr.

Cardiac evaluation of all four children who were diagnosed with SRNS as a result of mutations in podocin when they already had ESRD demonstrated severe LVH. These patients experienced repeated bouts of congestive heart failure.

Thirty-seven siblings without NS (first control group) underwent cardiac evaluation at the mean age of 7.4 ± 2.9 yr: 16 had normal genotype, and 21 were heterozygotes for the R138X mutation in podocin. None of the individuals with normal genotype had a cardiac disorder, and only one carrier was found to have cardiac anomaly, which consisted of a medium-sized atrial septal defect and mild pulmonary valve stenosis with a gradient of 27 mmHg.

All 22 patients who were aged 4.6 ± 3.9 yr and had severe persistent NS as a result of various causes other than mutations in podocin (second control group) had normal cardiac anatomy and function. The incidence of cardiac anomalies among patients with SRNS as a result of mutations in podocin was significantly higher than that of both control groups (P < 0.001 versus healthy siblings and P < 0.001 versus children with persistent NS as a result of other causes).

Discussion

We detected congenital cardiac anomalies in 16 of 18 children at the time of diagnosis of SRNS as a result of the homozygous R138X mutation in podocin. The identification of a nonsense mutation, resulting in truncation of an integral structural component of the glomerular barrier, explains the phenotype of massive proteinuria and SRNS. The leading cardiac defect was LVH followed by pulmonary stenosis and less frequently discrete subaortic stenosis, Ebstein anomaly of the tricuspid valve, and ventricular septal defect. The remarkably increased incidence of specific cardiac defects in children with SRNS described here exceeds by far the reported incidence of these anomalies in the general population (11) and points against a random association. For instance, pulmonary stenosis was detected in 33.3% of patients with SRNS compared with only 0.08 to 0.15% in the general population (12).

The association between familial SRNS and congenital cardiac malformations may be attributed to three distinct mechanisms: Mutated podocin, mutations in a gene that is closely linked to podocin, or homozygous mutations in an unlinked gene as expected in a highly consanguineous population such as that reported here. If cardiac anomalies and SRNS were two separate traits, then one would expect to find a similar incidence of cardiac defects among siblings who are not homozygous for a mutation in podocin. In fact, none of the unaffected siblings with normal genotype had a cardiac disorder, and only one carrier of the mutation had a heart anomaly. This proves unequivocally that cardiac anomalies and SRNS as a result of mutations in podocin do not represent an association by chance but rather are co-inherited. Whether the cardiac disorder that was detected in a carrier represents the effect of one podocin-mutated allele and a second somatic mutation in podocin or a different gene remains to be determined (13).

Nephrotic syndrome, unaccompanied by hypertension or renal failure, has not been shown to engender cardiac anomalies. This notion was substantiated by our finding that none of the studied 22 children with severe persistent NS as a result of various causes other than mutations in podocin had a cardiac anomaly. Therefore, massive proteinuria per se cannot account for the increased incidence of heart defects.

The first association between familial NS and cardiac involvement was reported over 40 yr ago (8). Four sisters, born to healthy parents, had SRNS that progressed to ESRD and were found to have cardiac murmurs. Further evaluation that was performed in two girls revealed infundibular pulmonary stenosis. Because this report preceded the definition of the molecular bases of the various recessive forms of SRNS, the exact cause of their renal disease remained unknown. Grech et al. (9) described four children who were from Malta and had CNF and cardiac malformations: Three had valvular pulmonary stenosis, and one had discrete subaortic stenosis. The diagnosis of CNF was based on histologic findings of kidney biopsies. It is unclear whether these four children were enrolled in a later study of the same population which demonstrated that there is a founder mutation in NPHS1 (R1160X) in children with CNF, with marked renal phenotypic variability (14). The authors concluded that the likelihood that two such rare conditions (CNF and these particular cardiac malformations) would be due to chance alone is low. A larger survey detected cardiac disorders in 12 of 42 children with CNF, which included pulmonary stenosis, cardiac hypertrophy, and atrial septal defect (15). The distribution of co-existing cardiac anomalies was even in all genotypes tested, whether they were homozygotes or compound heterozygotes. Cardiac hypertrophy was attributed by these researchers to hemodynamic changes resulting from hypoproteinemia, as marked improvement was noted after bilateral nephrectomy. A child who was from Turkey and had SRNS as a result of three different homozygous mutations in podocin and cardiac malformation, consisting of aortic valve stenosis with regurgitation, was presented recently (16). This case, which occurred in a child from a different population from ours and involved other mutations in podocin, supports our observation of the co-inheritance of these two traits.

The heart defects that were detected in our patients are similar to those reported in other children with familial SRNS and CNF, including primarily cardiac hypertrophy, pulmonary stenosis, and discrete subaortic stenosis (8,9,15). That a number of cardiac anomalies are shared by patients with CNF favors the mechanism of direct effect of nephrin and/or podocin instead of an indirect effect of a closely linked mutated gene.

Several lines of evidence support a possible role for these genes in normal heart development. The expression of nephrin in nonrenal tissues is not completely known: Northern hybridization did not reveal nephrin-RNA in fetal placenta, liver, brain, lung, muscle, or pancreas, but it was not performed in human fetal heart (4). In mouse embryos, nephrin was shown to be expressed in the kidney, the central nervous system, and the pancreas (17,18). There was no expression of murine nephrin in fetal heart.

Human podocin mRNA was found to be strongly expressed both in fetal and adult kidney. It is interesting that there was also a positive signal in human fetal heart but not in adult heart (6). The renal phenotype of podocin-deficient mice has been studied extensively, but no information has been provided concerning their cardiac status (19). An association has been described recently between heart disease and FSGS but not other forms of primary NS, with no significant difference in BP or hematocrit levels (20). Cardiac involvement included LVH and congestive heart failure. These patients had not been genotyped for mutations in podocin, and no data were available concerning their cardiac status at the time of diagnosis of FSGS.

Nephrin, encoded by NPHS1, is an integral membrane protein of the Ig superfamily and is a critical structural component of the slit diaphragm. The cytoplasmic tail of nephrin is tyrosine phosphorylated and recruits signaling intermediates that bind to the phosphorylated tyrosine residues, rendering it a signal transduction protein. Podocin, in turn, is a member of the stomatin protein family with a predicted hairpin-like structure localized to the insertion site of the slit diaphragm of podocytes. Podocin has been shown to be lipid-raft associated at the filtration slit (21). Lipid rafts are specialized microdomains of the plasma membrane with a unique lipid composition that are highly concentrated in signal transduction molecules. Podocin serves to recruit nephrin into lipid-raft microdomains, which is required for the proper initiation and augmentation of nephrin signaling (22). Studies of the effect of the R138X mutant in podocin, which is responsible for SRNS in our patients, showed that podocin may still interact with nephrin and get to the plasma membrane, but they are not targeted to the rafts. Therefore, this mutant cannot augment nephrin signal transduction.

Several genes have been identified as being responsible for various congenital heart diseases (23). It has been shown that mutations of most congenital heart diseases genes can engender more than one cardiac phenotype. LVH and pulmonary stenosis were the two most prevalent cardiac disorders detected in our patients with SRNS.

We speculate that the association between SRNS as a result of mutations in podocin and cardiac anomalies points to a causal role of podocin in normal cardiac development. The podocin transcript is expressed in fetal heart, and its product may interact with other peptides and affect the overall signal transduction. Mutated podocin may lead to abnormal signaling, resulting in congenital heart defects. The possibility that SRNS and cardiac defects are co-inherited but result from two closely linked mutated genes cannot be excluded on the basis of current data.

That all four patients with LVH recovered normal heart anatomy and function after successful kidney transplantation may reflect the compensatory effect of other genes later on in life, as podocin is not expressed in human adult heart. A similar pattern of complete resolution of hypertrophic cardiomyopathy was described previously in children with the idiopathic (or familial) form and in a child with Noonan syndrome (24). Because the natural history of podocin-associated SRNS is of ESRD during the first decade of life, it precludes the systematic study of LVH during this period independent of hypertension or CKD. Humoral factors that are associated with chronic renal failure and that improved after renal transplantation as well as better control of hypertension may also play a role in regression of the LVH (25).

Because heart anomalies are prevalent among children with SRNS as a result of mutations in podocin, complete cardiac evaluation is recommended at the time of diagnosis to enable proper follow-up and early intervention when indicated. Cardiac defects in these patients are not a contraindication to renal transplantation and have no bearing on the timing of transplantation. More studies are needed to document an increased incidence of cardiac anomalies among children with SRNS as a result of different mutations in NPHS2. Further research is mandatory to define precisely the mechanism underlying the association between SRNS as a result of mutations in podocin and heart defects.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • © 2006 American Society of Nephrology

References

  1. ↵
    Pollak MR: The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol23 :141 –146,2003
    OpenUrlCrossRefPubMed
  2. ↵
    Niaudet P: Genetic forms of nephrotic syndrome. Pediatr Nephrol19 :1313 –1318,2004
    OpenUrlCrossRefPubMed
  3. ↵
    Antignac C: Genetic models: Clues for understanding the pathogenesis of idiopathic nephrotic syndrome. J Clin Invest109 :447 –449,2002
    OpenUrlCrossRefPubMed
  4. ↵
    Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen N, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell1 :575 –582,1998
    OpenUrlCrossRefPubMed
  5. ↵
    Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, causes familial focal segmental glomerulosclerosis. Nat Genet24 :251 –256,2000
    OpenUrlCrossRefPubMed
  6. ↵
    Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet24 :349 –354,2000
    OpenUrlCrossRefPubMed
  7. ↵
    Frishberg Y, Rinat C, Megged O, Shapira E, Feinstein S, Raas-Rothschild A: Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol13 :400 –405,2002
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Fournier A, Paget M, Pauli A, Devin P: [Familial nephrotic syndromes. Nephrotic syndrome associated with congenital cardiopathy in 4 sisters]. Pediatrie18 :677 –685,1963
    OpenUrlPubMed
  9. ↵
    Grech V, Chan MKH, Vella C, Attard Montalto S, Rees P, Trompeter RS: Cardiac malformations associated with the congenital nephrotic syndrome. Pediatr Nephrol14 :1115 –1117,2000
    OpenUrlCrossRefPubMed
  10. ↵
    Roge CL, Silverman NH, Hart PA, Ray RM: Cardiac structure growth pattern determined by echocardiography. Circulation57 :285 –290,1978
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Rosenthal G: Prevalence of congenital heart disease. In: The Science and Practice of Pediatric Cardiology, 2nd Ed., edited by Garson A, Bricker JT, Fisher DJ, Neish SR, Baltimore, Williams & Wilkins,1998 , pp1089 –1093
  12. ↵
    Pradat P, Francannet C, Harris JA, Robert E: The epidemiology of cardiovascular defects, part I: A study based on data from three large registries of congenital malformations. Pediatric Cardiol24 :195 –221,2003
  13. ↵
    Reamon-Buettner SM, Borlak J: Somatic NKX2–5 mutations as a novel mechanism of disease in complex congenital heart disease. J Med Genet41 :684 –690,2004
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Koziell A, Grech V, Hussain S, Lee G, Lenkkeri U, Tryggvason K, Scambler P: Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet11 :379 –388,2002
    OpenUrlCrossRefPubMed
  15. ↵
    Patrakka J, Kestila M, Wartiovaara J, Ruotsalainen V, Tissari P, Lenkkeri U, Mannikko M, Visapaa I, Holmberg C, Rapola J, Tryggvason K, Jalanko H: Congenital nephrotic syndrome (NPHS1): Features resulting from different mutations in Finnish patients. Kidney Int58 :972 –980,2000
    OpenUrlCrossRefPubMed
  16. ↵
    Sonmez F, Mir S, Berdeli A, Aydogdu A, Altincik A: Triple homozygous podocin mutations in a patient with familial congenital focal segmental glomerulosclerosis associated with cardiac malformation [Abstract]. Nephrol Dial Transplant20 :226 ,2005
    OpenUrl
  17. ↵
    Putaala H, Sainio K, Sariola H, Tryggvason K: Primary structure of mouse and rat nephrin cDNA and structure and expression of the mouse gene. J Am Soc Nephrol11 :991 –1001,2000
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol genet10 :1 –8,2001
    OpenUrlCrossRefPubMed
  19. ↵
    Roselli S, Heidet L, Sich M, Henger A, Kretzler M, Gubler MC, Antignac C: Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol24 :550 –560,2004
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Adedoyin O, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H: Cardiac disease in children with primary glomerular disorders—Role of focal segmental glomerulosclerosis. Pediatr Nephrol19 :408 –412,2004
    OpenUrlCrossRefPubMed
  21. ↵
    Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest108 :1621 –1629,2001
    OpenUrlCrossRefPubMed
  22. ↵
    Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G, Benzing T: Molecular basis of the functional podocin-nephrin complex: Mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet12 :3397 –3405,2003
    OpenUrlCrossRefPubMed
  23. ↵
    Gelb BD: Genetic basis of congenital heart disease. Curr Opin Cardiol19 :110 –115,2004
    OpenUrlCrossRefPubMed
  24. ↵
    Skinner JR, Manzoor A, Hayes AM, Joffe HS, Martin RP: A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants. Heart77 :229 –233,1997
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Ferreira SRC, Moises VA, Tavares A, Pacheco-Silva A: Cardio-vascular effects of successful renal transplantation: A 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation74 :1580 –1587,2002
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 17 (1)
Journal of the American Society of Nephrology
Vol. 17, Issue 1
January 2006
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
The Heart of Children with Steroid-Resistant Nephrotic Syndrome: Is It All Podocin?
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Heart of Children with Steroid-Resistant Nephrotic Syndrome: Is It All Podocin?
Yaacov Frishberg, Sofia Feinstein, Choni Rinat, Rachel Becker-Cohen, Israela Lerer, Annick Raas-Rothschild, Benjamin Ferber, Amiram Nir
JASN Jan 2006, 17 (1) 227-231; DOI: 10.1681/ASN.2005060653

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
The Heart of Children with Steroid-Resistant Nephrotic Syndrome: Is It All Podocin?
Yaacov Frishberg, Sofia Feinstein, Choni Rinat, Rachel Becker-Cohen, Israela Lerer, Annick Raas-Rothschild, Benjamin Ferber, Amiram Nir
JASN Jan 2006, 17 (1) 227-231; DOI: 10.1681/ASN.2005060653
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
  • Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors
  • IgACE: A Placebo-Controlled, Randomized Trial of Angiotensin-Converting Enzyme Inhibitors in Children and Young People with IgA Nephropathy and Moderate Proteinuria
Show more Clinical Nephrology

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • This Month’s Highlights
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire